JPRN-UMIN000006483CompletedPhase 3
Double blind-randomized controlled trial for the efficacy of third line H. pylori eradication therapy between sitafloxacin-including regimen and sitafloxacin and metronidazole-including regimen - Double blind-randomized controlled trial for the efficacy of third line H. pylori eradication therapy
Keio University School of Medicine0 sites200 target enrollmentStarted: November 1, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Patients with allergy for quinolones 2. Patients with allergy for PPIs 3. Patients with severe liver injury and/or severe renal damage 4. Pregnancy or possible pregnancy 5. Patients who were recognized as inappropriate for entry
Investigators
Similar Trials
Completed
Phase 3
Double blind-randomized controlled trial for the efficacy of third line H. pylori eradication therapy between refabutin-including 10 days and 14 days regimeH. pylori-positve patients after the 2nd line eradication failureJPRN-UMIN000011963Keio University School of Medicine170
Recruiting
Phase 3
A study comparing two different methods of pain relief following cholecystectomyPost cholecystectomy pain reliefSLCTR/2016/011Department of Surgery, Faculty of Medicine, University of Kelaniya
Not yet recruiting
Not Applicable
To compare the effects of differences in the way injections are given in the back of spine and the direction with which the needle face on the duration of pain relief to the patients undergoing surgeries on bones of legCTRI/2020/06/026246SRM Medical College Hospital and Research Centre
Not yet recruiting
Phase 1
A randomized controlled trial for the fire acupuncture in the treatment of malignant pleural effusiomalignant pleural effusionITMCTR1900002848Guangxi Traditional Chinese Medical University Affiliated First Hospital
Active, not recruiting
Phase 1
Effectiveness of Botulinum toxin Type A injection (Dysport®) to restore quadriceps muscle balance and improve chronic knee paiChronic anterior knee pain?Musculoskeletal - Other muscular and skeletal disordersACTRN12605000775617Dr BJ Singer, School of Surgery and Pathology, The University of Western AustraliaMedical Research Foundation Building, Level 2, Rear 50 Murray Street, Perth, WA 600025